1. Home
  2. VCEL vs OI Comparison

VCEL vs OI Comparison

Compare VCEL & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • OI
  • Stock Information
  • Founded
  • VCEL 1989
  • OI 1903
  • Country
  • VCEL United States
  • OI United States
  • Employees
  • VCEL N/A
  • OI N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • OI Containers/Packaging
  • Sector
  • VCEL Health Care
  • OI Consumer Discretionary
  • Exchange
  • VCEL Nasdaq
  • OI Nasdaq
  • Market Cap
  • VCEL 2.1B
  • OI 2.2B
  • IPO Year
  • VCEL 1997
  • OI N/A
  • Fundamental
  • Price
  • VCEL $41.83
  • OI $15.12
  • Analyst Decision
  • VCEL Strong Buy
  • OI Buy
  • Analyst Count
  • VCEL 8
  • OI 8
  • Target Price
  • VCEL $62.00
  • OI $15.88
  • AVG Volume (30 Days)
  • VCEL 430.3K
  • OI 1.8M
  • Earning Date
  • VCEL 07-31-2025
  • OI 07-29-2025
  • Dividend Yield
  • VCEL N/A
  • OI N/A
  • EPS Growth
  • VCEL 521.85
  • OI N/A
  • EPS
  • VCEL 0.05
  • OI N/A
  • Revenue
  • VCEL $238,541,000.00
  • OI $6,505,000,000.00
  • Revenue This Year
  • VCEL $23.03
  • OI $1.90
  • Revenue Next Year
  • VCEL $24.52
  • OI $1.28
  • P/E Ratio
  • VCEL $805.02
  • OI N/A
  • Revenue Growth
  • VCEL 14.80
  • OI N/A
  • 52 Week Low
  • VCEL $37.39
  • OI $9.23
  • 52 Week High
  • VCEL $63.00
  • OI $15.58
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 47.28
  • OI 61.42
  • Support Level
  • VCEL $40.53
  • OI $14.64
  • Resistance Level
  • VCEL $43.57
  • OI $15.58
  • Average True Range (ATR)
  • VCEL 1.67
  • OI 0.43
  • MACD
  • VCEL -0.10
  • OI 0.07
  • Stochastic Oscillator
  • VCEL 27.68
  • OI 62.84

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: